Error: unable to get links from server. Please make sure that your site supports either file_get_contents() or the cURL library.
Wegovy shortage sees ‘off-label’ use of diabetes drug Ozempic
dpa picture alliance/alamy
In 2023, the use of the drug Wigovy (semaglutide) skyrocketed and changed weight management. There has never been an approved weight loss drug that is so effective yet considered sufficiently safe. “The medical treatment of obesity has been revolutionized,” he says. Daniel Drucker At the University of Toronto, Canada.
With near-constant media coverage, demand for Wegovy grew so high that some pharmacies in the United States, where the drug was launched, were in short supply…
Source: www.newscientist.com
